Along4, the famous "soon" will be when Sunrise produces irrefutable proof that Bavi blows the SOC overall survival numbers out of the water. Say 50% or more increase.
From there everyone will know the FDA will approve quickly. Such quick approval should lead to significant dollar partnering and/or Peregrine announcing a credible distribution deal.
The first domino will be at the first or second Sunrise look-in. Somewhere between eight weeks and seven months by my crystal ball.
Of course, there may be a solid partnering deal at any time that would ruin my fearless prediction.
GLTA, Especially Bavi-Arm Sunrise Patients,
Paul
News 
Market Data 
Discover 
AI
